Recent Findings from Washington University Has Provided New Information about Insurance (Venturing Into Health): Insurance

2025 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Current study results on Insurance have been published. According to news reporting out of St. Louis, Missouri, by NewsRx editors, the research stated, “In recent years, the landscape of venture capital (VC) investment in healthcare technologies has been altered by the introduction of new types of VC firms: those that have emerged from hospital systems and health insurers. However, the legal literature has not yet analyzed these new VC firms, the role they may play in healthcare innovation, and how innovation law and policy ought to consider their involvement.”

Our news journalists obtained a quote from the research from Washington University, “Hospital system and health insurer VC firms operate very differently than traditional VC firms, even those that have historically developed healthcare specializations. Instead of simply investing capital into start-up firms, hospital system and health insurer VC firms may also offer access to their networks of healthcare providers and to patient data, resources which may not be accessible to start-ups who partner only with traditional VC firms. When investing, hospital system and health insurer VC firms also act both as user innovators, hoping to adopt the technologies they invest in for themselves (to deliver care at a lower cost or to increase revenues), and as traditional investors, hoping to sell the technology to other hospital systems or insurers. Due to these dynamics, hospital system and health insurer VC firms do not fit easily within traditional healthcare innovation paradigms. As a result, they may be able to serve a unique innovation-encouraging role within the broader healthcare system, particularly with their specialized knowledge about healthcare delivery and services. They may also play a larger role in developing novel healthcare technologies, including those involving artificial intelligence. But they may also engage in innovation-stifling activities, either by investing in technologies which have insufficient evidence of safety and efficacy or by limiting the dissemination of innovative technologies.”

According to the news editors, the research concluded: “Legal and policy interventions may help encourage these innovative activities while simultaneously redressing potential patient harms.”

This research has been peer-reviewed.

For more information on this research see: Venturing Into Health. Fordham Law Review, 2025;94(1):131-179. Fordham Law Review can be contacted at: Fordham Univ, School Law, 140 W 62ND Street, New York, NY 10023, USA.

Our news journalists report that additional information may be obtained by contacting Rachel E. Sachs, Washington University, School of Law, Law, St. Louis, MO 63130, United States.

(Our reports deliver fact-based news of research and discoveries from around the world.)